Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K van Besien

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Transplantation|December 27, 1996
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimusD Przepiorka, C Ippoliti, I Khouri, et al.
Bone Marrow Transplantation|October 19, 2001
Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplantS M Devine, R Sanborn, E Jessop, et al.
Bone Marrow Transplantation|September 12, 2007
Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantationD A Pollyea, A S Artz, W Stock, et al.
Bone Marrow Transplantation|March 1, 1997
Allogeneic blood stem cell transplantation in advanced hematologic cancersD Przepiorka, P Anderlini, C Ippoliti, et al.
Bone Marrow Transplantation|June 20, 2003
Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignanciesK van Besien, S Devine, A Wickrema, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusionJ A Sosman, P Stiff, S M Moss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant RegistryJ M Vose, M J Zhang, P A Rowlings, et al.
Blood|March 7, 1998
Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphomaK van Besien, C S Ha, S Murphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescueS Giralt, D Weber, M Colome, et al.
British Journal of Haematology|May 1, 1997
Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host diseaseI F Khouri, D Przepiorka, K van Besien, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Transplantation|December 27, 1996
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimusD Przepiorka, C Ippoliti, I Khouri, et al.
Bone Marrow Transplantation|October 19, 2001
Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplantS M Devine, R Sanborn, E Jessop, et al.
Bone Marrow Transplantation|September 12, 2007
Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantationD A Pollyea, A S Artz, W Stock, et al.
Bone Marrow Transplantation|March 1, 1997
Allogeneic blood stem cell transplantation in advanced hematologic cancersD Przepiorka, P Anderlini, C Ippoliti, et al.
Bone Marrow Transplantation|June 20, 2003
Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignanciesK van Besien, S Devine, A Wickrema, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusionJ A Sosman, P Stiff, S M Moss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant RegistryJ M Vose, M J Zhang, P A Rowlings, et al.
Blood|March 7, 1998
Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphomaK van Besien, C S Ha, S Murphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescueS Giralt, D Weber, M Colome, et al.
British Journal of Haematology|May 1, 1997
Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host diseaseI F Khouri, D Przepiorka, K van Besien, et al.
Pageof 8